This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Medifast (MED) Q3 Earnings Top Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Medifast's (MED) Q3 results reflect challenges in customer acquisition. However, cost-reduction efforts and efficiency improvements as part of the "Fuel for the Future" plan bode well.
Wall Street Analysts Predict a 54.51% Upside in Vital Farms (VITL): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 54.5% upside potential for Vital Farms (VITL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
New Strong Buy Stocks for November 6th
by Zacks Equity Research
LPG, APPF, FTDR, FSFG and VITL have been added to the Zacks Rank #1 (Strong Buy) List on November 6, 2023.
Conagra Brands (CAG) Q1 Earnings Top Estimates
by Zacks Equity Research
Conagra Brands (CAG) delivered earnings and revenue surprises of 10% and 1.42%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?
McCormick (MKC) Meets Q3 Earnings Estimates
by Zacks Equity Research
McCormick (MKC) delivered earnings and revenue surprises of 0% and 0.41%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?
CalMaine (CALM) to Acquire Few Assets of Fassio Egg Farms
by Zacks Equity Research
CalMaine Foods (CALM) to acquire Fassio Egg Farms' certain assets related to commercial shell egg production and processing business.
Vital Farms (VITL) Unveils Ambitious Long-Term Financial Goals
by Zacks Equity Research
Vital Farms (VITL) is on track to deliver on its long-term revenue and EBITDA goals, propelled by distribution point enhancement.
TreeHouse Foods (THS) Q2 Earnings Beat Estimates, View Raised
by Zacks Equity Research
TreeHouse Foods' (THS) second-quarter fiscal 2023 results reflect gains from pricing actions to counter cost inflation. Management raises net sales and adjusted EBITDA guidance for fiscal 2023.
Vital Farms (VITL) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Vital Farms (VITL) continues its strong second-quarter performance through collaborative stakeholder engagement and passionate commitment to quality products amid higher input cost challenges.
Vital Farms (VITL) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 150% and 1.49%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Kellogg (K) Files Form 10 Statement for its Planned Split Off
by Zacks Equity Research
Kellogg (K) files a Form 10 registration statement with the U.S. Securities and Exchange Commission related to the planned separation, which is expected to conclude in the fourth quarter.
Vital Farms (VITL) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Vital Farms (VITL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Conagra Brands (CAG) Exhibits Bright Prospects, Risks Persist
by Zacks Equity Research
Conagra Brands (CAG) is poised to benefit from strength across its Foodservice and Frozen businesses, along with its effective pricing actions. However, escalating operating expenses remain a concern.
Lamb Weston (LW) Stock Up 28.3% YTD: What's Driving the Rally?
by Zacks Equity Research
Lamb Weston (LW) is poised to benefit from its business strength, expansionary efforts, acquired assets and shareholder-friendly policies.
How Much Upside is Left in Vital Farms (VITL)? Wall Street Analysts Think 30.16%
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 30.2% in Vital Farms (VITL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Will Strong Brand Help Keurig Dr Pepper (KDP) Amid Inflation?
by Zacks Equity Research
Keurig Dr Pepper (KDP) benefits from continued strength in the Packaged Beverages segment, strong market share gains and robust pricing actions. However, rising inflation is a concern.
Vital Farms (VITL) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 300% and 17.40%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
TreeHouse Foods (THS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
TreeHouse (THS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vital Farms (VITL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Vital Farms (VITL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hershey (HSY) Looks Appetizing on Pricing & Strategic Buyouts
by Zacks Equity Research
Hershey (HSY) is undertaking strategic pricing initiatives to improve its performance. The company's focus on buyouts is yielding.
Keurig Dr Pepper (KDP) Banks On Brand Strength Amid Inflation
by Zacks Equity Research
Keurig Dr Pepper (KDP) benefits from continued strength in the Packaged Beverages segment, strong market share gains and robust pricing actions. However, rising inflation is concerning.
Kimberly-Clark (KMB) Looks Great on Pricing & Saving Efforts
by Zacks Equity Research
Kimberly-Clark (KMB) benefits from its strong pricing and saving efforts amid cost inflation. A focus on three growth pillars is also working well.
Kellogg (K) Benefits From Portfolio Strength & Acquisitions
by Zacks Equity Research
Kellogg (K) is dedicated to augmenting its portfolio by adding more products under existing brands, innovation and marketing initiatives.
Here's Why FEMSA (FMX) is Marching Ahead of Its Industry
by Zacks Equity Research
FEMSA (FMX) looks good on continued growth in the digital business, as well as strength across all segments. The expansion strategy of its national distribution platform bodes well.
The Zacks Analyst Blog Highlights Hershey's, General Mills, Mondelez and Vital Farms
by Zacks Equity Research
Hershey's, General Mills, Mondelez and Vital Farms are included in this Analyst Blog.